The mechanism is elegant in its destructiveness. Robert F. Kennedy Jr. doesn't need to fight the pharmaceutical industry, override the FDA, or persuade Congress. He just needs to leave a chair empty. The Advisory Committee on Immunization Practices — the body whose recommendations trigger mandatory insurance coverage of vaccines — has no functioning members, no replacements nominated, and no timeline for reconstitution. Every month that passes without an ACIP recommendation for a newly approved vaccine adds roughly a year to the coverage delay for Americans. Ron Kroening, a 63-year-old retired public health worker in Oklahoma, discovered this firsthand when he was charged a $40 co-pay for the new Moderna mRNA flu vaccine — a shot approved by the FDA in August for adults 50 and older. He'd never paid for a flu shot before. His insurer told him the reason was simple: no ACIP recommendation, no coverage requirement. If the committee doesn't recommend the shot by the end of the year, coverage could be delayed until January 2029 at the earliest. The insurance coverage timeline is the load-bearing wall here. Under the Affordable Care Act, insurers have until the next plan year — which usually starts in January — at least a year after an ACIP recommendation to implement coverage. Miss a December recommendation window and the delay cascades: a January 2027 recommendation pushes mandatory coverage to January 2029. Kennedy's strategy of leaving ACIP vacant turns this bureaucratic clock into a weapon. Every month of inaction pushes coverage further out for every new vaccine that reaches the market. The ripple effects extend beyond insurance. Some states prohibit pharmacists from administering vaccines without an ACIP recommendation. Previous ACIP decisions made before the committee was disbanded have been frozen by court order, including September 2025 recommendations on new RSV prevention shots. A now-voided vote to end the universal birth dose of the hepatitis B vaccine is already influencing state-level legislation, as New Hampshire considers an anti-vaccine bill inspired by the defunct committee's brief deliberations. Kennedy's own lawyer, Aaron Siri, has said publicly that the White House and Department of Justice are "doing everything they can to make sure that there is no functioning vaccine committee." This is not speculation about intent — it's stated strategy from Kennedy's inner circle. Legal experts note Kennedy could undergo the correct process for appointing new members at any time. He hasn't. UC Law San Francisco professor Dorit Reiss points out the advantage: Kennedy's handpicked ACIP members were "embarrassingly" uninformed and slow to deliver the schedule changes he wanted. Going around ACIP entirely gives him more control. The insurance industry group AHIP has pledged to continue covering shots recommended as of September 2025, and some insurers may voluntarily cover new vaccines before required. But voluntary coverage is not a system — it's a patchwork that varies by plan, by state, and by employer. The structural guarantee that made vaccines effectively free for most Americans depended on ACIP functioning as an independent scientific body. That body is gone. Reiss warns that even after legal proceedings conclude, ACIP may not return to its prior form. Kennedy has "aggressively undermined" trust in the committee's independence. "Without dramatic changes, it's probably not coming back the way it was," she said. "This has shown that ACIP is politically vulnerable, and I think if we want ACIP to go back to the way it was, we're going to need a statute that gives it some protection." The damage isn't just to this year's flu shot — it's to the institutional architecture that made universal vaccine access possible in the first place.
